01 1MINSHENG GROUP SHAOXING PHARMACEUTICAL CO,. LTD.
02 1UQUIFA Mexico, S.A. DE C.V.
01 1PYRANTEL TARTRATE
02 1Pyrantel Tartrate Zeolex
01 1China
02 1Spain
NDC Package Code : 13371-215
Start Marketing Date : 2013-07-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52286-0020
Start Marketing Date : 2009-11-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Pyrantel Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyrantel Tartrate, including repackagers and relabelers. The FDA regulates Pyrantel Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyrantel Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pyrantel Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pyrantel Tartrate supplier is an individual or a company that provides Pyrantel Tartrate active pharmaceutical ingredient (API) or Pyrantel Tartrate finished formulations upon request. The Pyrantel Tartrate suppliers may include Pyrantel Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Pyrantel Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pyrantel Tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pyrantel Tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pyrantel Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pyrantel Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pyrantel Tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pyrantel Tartrate suppliers with NDC on PharmaCompass.
We have 2 companies offering Pyrantel Tartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
